Circulating tumour-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer
β Scribed by B. G. Ward; D. J. Cruickshank
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 351 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
A radioimmunometric sandwich assay for the tumour-associated antigen defined by the monoclonal antibody (MAb) HMFGZ, has been used to measure serum levels of the antigen in 76 healthy controls, 38 ovarian carcinoma patients preoperatively, 98 patients 2 to 6 weeks after surgery and 36 patients at relapse or in complete remission at I 2 months. HMFGZ antigen levels were elevated in 33% of stage-I and 62% of Il-IV patients pre-operatively; they reflected bulk of disease post-surgically and were signficantly higher in patients in relapse than in those who were in complete remission. HMFG2 antigen levels predicted the clinical course of disease in the majority of patients.
π SIMILAR VOLUMES
The cancer-associated epitope defined by the monoclonal antibody (MAb) 9H8 was shown to be closely related to the T antigen (Thornsen-Friedenreich antigen) by its sensitivity to 0-glycanase treatment of a mucin glycopeptide known to express this epitope. The reactivity with this glycopeptide increas